Martine van Vugt
Genmab
Executive Vice President and Chief Strategy Officer

Paul Peter Tak
Candel Therapeutics
President & CEO

Xander Koolman
Free University Amsterdam
Chair and Professor Health Economics

Conny Helder
Health Holland | FAST | Oncode Accelerator
Board member | Chair

Jakob van der Waarden
Ministry of Economic Affairs
Directeur Nationaal Groeifonds

Carl Moons
UMC Utrecht | AI4Health
Professor

Marc van Voorst tot Voorst
Forbion
Head of Public Affairs

Annemiek Verkamman
HollandBio
Managing Director

Tom van Helmond
Loyens & Loeff
Managing Partner NL

Carlijn Bouten
TU/e | HEALTH Institute
Professor | Scientific Director

Barend Bouma
NLO
Partner | European Patent Attorney

Nazma Ilahibaks
JAMA Therapeutics
CEO and Co-founder

Eline van Beest
Thuja Capital | TU Delft
Operating Partner | Professor

Tim Knotnerus
Agomab Therapeutics
CEO

Saco de Visser
FAST | Amsterdam UMC
Scientific Director | Professor

Carmen van Vilsteren
Angel Investor
Co-author of Lancet Paper Women's Health

Hans Schikan
Chairman & Board Member of various biotech companies

Nathalie ter Wengel
Pfizer
Europe Worldwide BD Lead & Global Scouting Team Lead

Cara Antoine
EVP & Chief Technology, Innovation, AI & Portfolio Officer

Jorden Evegaars
jordenbastian
Founder | Fractional Operating Partner

Katleen De Stobbeleir
Vlerick Business School
Professor of Leadership

Andrew Plank
Roche
General Manager Netherlands

Shana Wang
PathCision
CEO and Co-Founder

Christoph Korpus
Byondis
CEO

Sebastian Asprella
EMA
Programme Lead, EU Competitiveness

Ilya Burkov
Nebius
Global Head of Scientific AI & Healthcare